First cannabis-derived drug authorised for France

France has for the first time approved prescription use of a drug derived from cannabis—a mouth spray used to treat multiple sclerosis (MS) symptoms, the government said Thursday.

The medicine, called Sativex, is already authorised in several European neighbours, but had remained off-limits in France due to a ban on any products derived from the marijuana plant.

The health ministry published a policy change last June, opening the door for medical use of the drug's active ingredients.

The first market authorisation was given on Wednesday by the National Agency for Drug Safety (ANSM), the ministry said.

Sativex, produced by the British firm GW Pharmaceuticals, has been approved for use in alleviating muscle stiffness and spasms from MS.

"The market authorisation is an interim step" before the drug becomes available from pharmacies, but on prescription only, said a ministry statement.

The spray's main active ingredients are delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD).

ANSM official Nathalie Richard said Sativex was not recommended for breastfeeding or pregnant women or people with a history of psychosis.

Medical cannabis use is already a reality in countries like the Netherlands, Spain, Italy, Germany and Britain, Canada, Australia and some American states.

In Canada, Sativex is also used to alleviate pain associated with cancer.

New York Governor Andrew Cuomo announced Wednesday he will authorise medical marijuana use, making his the 21st US state to do so.

add to favorites email to friend print save as pdf

Related Stories

Pot-based prescription drug looks for FDA OK

Jan 23, 2012

A quarter-century after the U.S. Food and Drug Administration approved the first prescription drugs based on the main psychoactive ingredient in marijuana, additional medicines derived from or inspired by ...

Washington state approves rules for pot industry

Oct 16, 2013

Washington became the second U.S. state to adopt rules for the recreational sale of marijuana Wednesday, setting what advocates hope will become a template for the drug's legalization around the world.

Czechs in quandary over legal medical marijuana

Nov 15, 2013

(AP)—Just three years ago, the only thing that Zdenek Majzlik knew about cannabis was that it's good stuff for making rope. Today, the 67-year-old retired nuclear power plant employee is an experienced ...

Recommended for you

US approves new, hard-to-abuse hydrocodone pill (Update)

7 hours ago

U.S. government health regulators on Thursday approved the first hard-to-abuse version of the painkiller hydrocodone, offering an alternative to a similar medication that has been widely criticized for lacking ...

Soaring generic drug prices draw Senate scrutiny

11 hours ago

Some low-cost generic drugs that have helped restrain health care costs for decades are seeing unexpected price spikes of up to 8,000 percent, prompting a backlash from patients, pharmacists and now Washington ...

Only half of patients take their medications as prescribed

21 hours ago

The cost of patients not taking their medications as prescribed can be substantial in terms of their health. Although a large amount of research evidence has tried to address this problem, there are no well-established ...

Interpol call for roadmap to tackle fake drugs

Nov 19, 2014

Interpol on Wednesday called for a greater global response to pharmaceutical crime as it warned criminal gangs were capitalising on weaknesses in legislation and border controls.

Empagliflozin in type 2 diabetes: Added benefit not proven

Nov 19, 2014

Empagliflozin (trade name Jardiance) has been approved since May 2014 for adults with type 2 diabetes mellitus in whom diet and exercise alone do not provide adequate glycaemic control. The German Institute for Quality and ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.